130 related articles for article (PubMed ID: 6319504)
1. Production of intraepidermal microabscesses by topical application of leukotriene B4.
Camp R; Jones RR; Brain S; Woollard P; Greaves M
J Invest Dermatol; 1984 Feb; 82(2):202-4. PubMed ID: 6319504
[TBL] [Abstract][Full Text] [Related]
2. The responses of normal and psoriatic skin to single and multiple topical applications of leukotriene B4.
Wong E; Camp RD; Greaves MW
J Invest Dermatol; 1985 May; 84(5):421-3. PubMed ID: 2987362
[TBL] [Abstract][Full Text] [Related]
3. Epidermal hyperproliferation following the induction of microabscesses by leukotriene B4.
Bauer FW; van de Kerkhof PC; Maassen-de Grood RM
Br J Dermatol; 1986 Apr; 114(4):409-12. PubMed ID: 3008801
[TBL] [Abstract][Full Text] [Related]
4. The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis.
Brain S; Camp R; Dowd P; Black AK; Greaves M
J Invest Dermatol; 1984 Jul; 83(1):70-3. PubMed ID: 6330213
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate inhibits the leukotriene B4 induced intraepidermal accumulation of polymorphonuclear leukocytes.
van de Kerkhof PC; Bauer FW; Maassen-de Grood RM
Br J Dermatol; 1985 Sep; 113(3):251a-255a. PubMed ID: 2998429
[TBL] [Abstract][Full Text] [Related]
6. The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene-B4--an immunohistochemical study.
de Jong EM; van Erp PE; van Vlijmen IM; van de Kerkhof PC
Clin Exp Dermatol; 1992 Nov; 17(6):413-20. PubMed ID: 1336720
[TBL] [Abstract][Full Text] [Related]
7. Response of polymorphonuclear leukocytes to topical leukotriene B4 in healthy and psoriatic skin.
Lammers AM; van de Kerkhof PC
Br J Dermatol; 1987 Apr; 116(4):521-4. PubMed ID: 3034322
[TBL] [Abstract][Full Text] [Related]
8. The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111).
van Pelt JP; de Jong EM; van Erp PE; Mitchell MI; Marder P; Spaethe SM; van Hooijdonk CA; Kuijpers AL; van de Kerkhof PC
Biochem Pharmacol; 1997 Apr; 53(7):1005-12. PubMed ID: 9174114
[TBL] [Abstract][Full Text] [Related]
9. Generation of leukotrienes from normal epidermis and their demonstration in cutaneous disease.
Rosenbach T; Grabbe J; Möller A; Schwanitz HJ; Czarnetzki BM
Br J Dermatol; 1985 Jul; 113 Suppl 28():157-67. PubMed ID: 2990517
[TBL] [Abstract][Full Text] [Related]
10. Response of psoriatic lesions to multiple applications of leukotriene B4 and 12-HETE.
Norris PG; Schofield O; Dowd PM; Greaves MW
Dermatologica; 1987; 174(5):219-23. PubMed ID: 3034690
[TBL] [Abstract][Full Text] [Related]
11. Intraepidermal accumulation of polymorphonuclear leukocytes in annular pustular psoriasis.
van de Kerkhof PC; Lammers AM
Dermatologica; 1988; 176(6):282-7. PubMed ID: 2841175
[TBL] [Abstract][Full Text] [Related]
12. Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions.
Lammers AM; van de Kerkhof PC
Br J Dermatol; 1987 Nov; 117(5):541-4. PubMed ID: 2825753
[TBL] [Abstract][Full Text] [Related]
13. Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions.
Fogh K; Herlin T; Kragballe K
J Invest Dermatol; 1989 Jun; 92(6):837-41. PubMed ID: 2542417
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of the cellular response of the rat conjunctiva to topically applied leukotriene B4.
Trocmé SD; Gilbert CM; Allansmith MR; Bloch KJ; Abelson MB
Ophthalmic Res; 1989; 21(4):297-302. PubMed ID: 2555760
[TBL] [Abstract][Full Text] [Related]
15. Epidermal cell-polymorphonuclear leukocyte cooperation in the formation of leukotriene B4 by transcellular biosynthesis.
Solá J; Godessart N; Vila L; Puig L; de Moragas JM
J Invest Dermatol; 1992 Mar; 98(3):333-9. PubMed ID: 1312107
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene B4-like material in scale of psoriatic skin lesions.
Brain SD; Camp RD; Cunningham FM; Dowd PM; Greaves MW; Black AK
Br J Pharmacol; 1984 Sep; 83(1):313-7. PubMed ID: 6091827
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of leukotriene B4 (LTB4)-induced neutrophil emigration by 20-hydroxy LTB4: implications for the regulation of inflammatory responses.
Pettipher ER; Salter ED; Breslow R; Raycroft L; Showell HJ
Br J Pharmacol; 1993 Sep; 110(1):423-7. PubMed ID: 8220903
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene B4 formation during human neutrophil keratinocyte interactions: evidence for transformation of leukotriene A4 by putative keratinocyte leukotriene A4 hydrolase.
Iversen L; Fogh K; Ziboh VA; Kristensen P; Schmedes A; Kragballe K
J Invest Dermatol; 1993 Mar; 100(3):293-8. PubMed ID: 8382716
[TBL] [Abstract][Full Text] [Related]
19. Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions.
Seyger MM; van Pelt JP; van den Born J; Latijnhouwers MA; de Jong EM
Arch Dermatol Res; 1997 May; 289(6):331-6. PubMed ID: 9209678
[TBL] [Abstract][Full Text] [Related]
20. Application of leukotriene B4 and reflectance confocal microscopy as a noninvasive in vivo model to study the dynamics of skin inflammation.
Peppelman M; Wolberink EA; Gerritsen MJ; van de Kerkhof PC; van Erp PE
Skin Res Technol; 2015 May; 21(2):232-40. PubMed ID: 25156913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
